| Clozapine-induced urinary incontinence: incidence and treatment with ephedrine. | |
| | |
MedLine Citation:
|
PMID: 8968299 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Treatment with the atypical antipsychotic drug clozapine appears to be associated with an increased incidence of urinary incontinence (UI). We posited that the potent anti-alpha-adrenergic effects of clozapine were involved, and hence that an alpha-adrenergic agonist would reduce UI. We tested this hypothesis by using ephedrine, an approved alpha-adrenergic agonist. METHOD: Fifty-seven inpatients with schizophrenia or schizoaffective disorder (DSM-IV) who met the Kane criteria for being treatment refractory were treated with clozapine (75-900 mg/day). Patients who developed UI were then openly treated with ephedrine in increasing doses until UI was attenuated or a dose of 150 mg/day was attained. RESULTS: Seventeen patients developed UI as evidenced by either urine-stained sheets/clothing or direct patient reports. In 2 cases, the UI was sufficiently severe that adult diapers had to be used. Comparison of patients who developed UI and those who did not showed that UI was associated with female gender and with concomitant treatment with typical antipsychotic drugs. One patient was treated with a behavioral program, but the remaining 16 patients were treated with ephedrine. Ephedrine treatment was very effective, with 15/16 patients showing improvement within 24 hours after reaching maximum ephedrine dosage. Twelve of 16 (including the 2 most severe) eventually had a complete remission of their UI. In the remaining 4 patients, 3 had a reduction in the frequency of UI and 1 showed no response. These benefits have been maintained over the course of 12 months of subsequent treatment for several patients. There were no side effects associated with the use of ephedrine nor were there any changes in neuropsychiatric status. CONCLUSION: Ephedrine appears to be a safe and effective treatment clozapine-associated UI. By inference, it is likely that clozapine may cause UI via its anti-alpha-adrenergic properties. |
| | |
Authors:
|
M A Fuller; M C Borovicka; G E Jaskiw; M R Simon; K Kwon; P E Konicki |
Related Documents
:
|
1347479 - Tardive dyskinesia. patients' lack of awareness of movement disorder. 8908689 - Are reduced head circumference at birth and increased obstetric complications associate... 17287089 - Assessment of motivation to change substance use in dually-diagnosed schizophrenia pati... 15167409 - Insight in relation to psychosocial adjustment in schizophrenia. 14638589 - Smaller anterior hippocampal formation volume in antipsychotic-naive patients with firs... 7934059 - Spiperone binding capacity in lymphocytes of patients with alcohol- and drug-induced ps... 9146579 - Nonoperative treatment of major blunt renal lacerations with urinary extravasation. 20854189 - Effects of lng-ius on nerve growth factor and its receptors expression in patients with... 324369 - The role of ethanol in cardiac disease. |
Publication Detail:
|
Type: Case Reports; Clinical Trial; Journal Article |
Journal Detail:
|
Title: The Journal of clinical psychiatry Volume: 57 ISSN: 0160-6689 ISO Abbreviation: J Clin Psychiatry Publication Date: 1996 Nov |
Date Detail:
|
Created Date: 1997-01-13 Completed Date: 1997-01-13 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7801243 Medline TA: J Clin Psychiatry Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 514-8 Citation Subset: IM |
Affiliation:
|
Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic alpha-Agonists
/
therapeutic use* Adult Aged Antipsychotic Agents / adverse effects*, therapeutic use Clozapine / adverse effects*, therapeutic use Drug Therapy, Combination Ephedrine / therapeutic use* Female Humans Incidence Male Middle Aged Psychotic Disorders / drug therapy Schizophrenia / drug therapy Treatment Outcome Urinary Incontinence / chemically induced*, drug therapy, epidemiology |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic alpha-Agonists; 0/Antipsychotic Agents; 299-42-3/Ephedrine; 5786-21-0/Clozapine |
| Comments/Corrections | |
Comment In:
|
J Clin Psychiatry. 1997 Sep;58(9):404
[PMID:
9378693
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The relative contributions of psychiatric symptoms and AIDS knowledge to HIV risk behaviors among pe...
Next Document: Paroxetine in social phobia.